Weiss Multi-Strategy Advisers’s Structure Therapeutics GPCR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-48,914	Closed	-$1.99M	–	209
2023 Q4	$1.99M	Buy	48,914 +22,977	+89%	+$1.32M	0.05%	371
2023 Q3	$1.31M	Buy	25,937 +10,764	+71%	+$347K	0.03%	417
2023 Q2	$631K	Buy	+15,173	New	+$425K	0.01%	565

Other funds holding GPCR

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Weiss Multi-Strategy Advisers's GPCR Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Structure Therapeutics (GPCR) in Q1 2024, closing a stake of 48,914 shares — an estimated $1.99M sold.

Weiss Multi-Strategy Advisers first reported a position in GPCR in Q2 2023 and held it in 3 quarters. The position peaked at $1.99M in Q4 2023. 119 funds tracked by Wall St. Rank hold GPCR as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining Structure Therapeutics position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 48,914 Structure Therapeutics shares in Q1 2024, an estimated $1.99M.
Weiss Multi-Strategy Advisers first reported a position in Structure Therapeutics in Q2 2023 and held it in 3 quarters.
Weiss Multi-Strategy Advisers's Structure Therapeutics position peaked at $1.99M in Q4 2023.
119 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.